Aspen Pharmacare slashed its debt mountain and delivered stronger cash flow in financial 2020, reaping the benefits of the stockpiling of everyday essentials by locked-down consumers and raising hopes that it could reopen its dividend taps in coming years.

Aspen, which also operates in several African countries, Australia and Latin America, has been among the winners at a time when the worldwide focus on fighting the Covid-19 pandemic saw a reduction in demand for treatment of other communicable diseases.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now